HuGE Literature Finder
|
||
Records 1-22
|
Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation.
Journal of medical biochemistry 2019 Mar 38 (1): 38-44. Isailovic Tatjana, Milicevic Ivana, Macut Djuro, Petakov Milan, Ognjanovic Sanja, Popovic Bojana, Antic Ivana Bozic, Bogavac Tamara, Kovacevic Valentina Elezovic, Ilic Dusan, Damjanovic Svetoz |
|
Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Endocrinology 2018 Jul . Wei Zhe, Sun Bin, Wang Zong-Ping, He Jin-Wei, Fu Wen-Zhen, Fan You-Ben, Zhang Zhen-L |
|
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Endocrine 2016 Feb . Sanpaolo E, Miroballo M, Corbetta S, Verdelli C, Baorda F, Balsamo T, Graziano P, Fabrizio F P, Cinque L, Scillitani A, Muscarella L A, Guarnieri Vi |
|
Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
European journal of endocrinology / European Federation of Endocrine Societies 2014 Sep 171 (3): 335-42. Longuini Viviane C, Lourenço Delmar M, Sekiya Tomoko, Meirelles Osorio, Goncalves Tatiana D, Coutinho Flavia L, Francisco Guilherme, Osaki Luciana H, Chammas Roger, Alves Venancio A F, Siqueira Sheila A C, Schlesinger David, Naslavsky Michel S, Zatz Mayana, Duarte Yeda A O, Lebrão Maria Lucia, Gama Patricia, Lee Misu, Molatore Sara, Pereira Maria Adelaide A, Jallad Raquel S, Bronstein Marcello D, Cunha-Neto Malebranche B, Liberman Bernardo, Fragoso Maria Candida B V, Toledo Sergio P A, Pellegata Natalia S, Toledo Rodrigo |
|
p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Annales d'endocrinologie 2014 Jul 75 (3): 133-40. Nozières Cecile, Zhang Chang-Xian, Buffet Alexandre, Dupasquier Stéphanie, Vargas-Poussou Rosa, Guillaud-Bataille Marine, Cordier-Bussat Martine, Ruszniewski Philippe, Christin-Maitre Sophie, Murat Arnaud, Groussin Lionel, Vezzosi Delphine, Cardot-Bauters Catherine, Hervieu Valérie, Joly Marie-Odile, Giraud Sophie, Odou Marie-Françoise, Gimenez-Roqueplo Anne-Paule, Goudet Pierre, Borson-Chazot Françoise, Calender Alain, |
|
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
The Journal of clinical endocrinology and metabolism 2013 Jul 98 (7): 2800-10. Pardi Elena, Marcocci Claudio, Borsari Simona, Saponaro Federica, Torregrossa Liborio, Tancredi Mariella, Raspini Benedetta, Basolo Fulvio, Cetani Filome |
|
MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2013 Feb 168 (2): 119-28. Alvelos Maria Inês, Vinagre João, Fonseca Elsa, Barbosa Eva, Teixeira-Gomes José, Sobrinho-Simões Manuel, Soares Pau |
|
Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.
Clinical endocrinology 2012 Jan 76 (1): 67-71. van Wijk J P H, Dreijerink K M A, Pieterman C R C, Lips C J M, Zelissen P M J, Valk G |
|
Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism.
Hormones & cancer 2011 Dec . Starker LF, Akerström T, Long WD, Delgado-Verdugo A, Donovan P, Udelsman R, Lifton RP, Carling T |
|
Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
The Journal of clinical endocrinology and metabolism 2011 Apr 96 (4): E701-6. Costa-Guda Jessica, Marinoni Ilaria, Molatore Sara, Pellegata Natalia S, Arnold Andr |
|
Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?
World journal of surgery 2010 Jun 34 (6): 1294-8. Skandarajah Anita, Barlier Anne, Morlet-Barlat Nathalie, Sebag Frederic, Enjalbert Alain, Conte-Devolx Bernard, Henry Jean-Franço |
|
Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Journal of endocrinological investigation 2009 Jun 32 (6): 512-8. Vierimaa O, Villablanca A, Alimov A, Georgitsi M, Raitila A, Vahteristo P, Larsson C, Ruokonen A, Eloranta E, Ebeling T M L, Ignatius J, Aaltonen L A, Leisti J, Salmela P |
|
Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Clinical endocrinology 2009 Apr 70 (4): 575-81. Pieterman C R C, Schreinemakers J M J, Koppeschaar H P F, Vriens M R, Rinkes I H M Borel, Zonnenberg B A, van der Luijt R B, Valk G |
|
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
Clinical endocrinology 2009 Feb 70 (2): 259-64. Igreja Susana, Chahal Harvinder S, Akker Scott A, Gueorguiev Maria, Popovic Vera, Damjanovic Svetozar, Burman Pia, Wass John A, Quinton Richard, Grossman Ashley B, Korbonits Már |
|
Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2007 Sep 115 (8): 509-17. Schaaf L, Pickel J, Zinner K, Hering U, Höfler M, Goretzki P E, Spelsberg F, Raue F, von zur Mühlen A, Gerl H, Hensen J, Bartsch D K, Rothmund M, Schneyer U, Dralle H, Engelbach M, Karges W, Stalla G K, Höppner |
|
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
The Journal of clinical endocrinology and metabolism 2007 Aug 92 (8): 3321-5. Georgitsi Marianthi, Raitila Anniina, Karhu Auli, van der Luijt Rob B, Aalfs Cora M, Sane Timo, Vierimaa Outi, Mäkinen Markus J, Tuppurainen Karoliina, Paschke Ralph, Gimm Oliver, Koch Christian A, Gündogdu Sadi, Lucassen Anneke, Tischkowitz Marc, Izatt Louise, Aylwin Simon, Bano Gul, Hodgson Shirley, De Menis Ernesto, Launonen Virpi, Vahteristo Pia, Aaltonen Lauri |
|
Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics.
Journal of endocrinological investigation 2004 Dec 27 (11): 1015-21. Scarpelli D, D'Aloiso L, Arturi F, Scillitani A, Presta I, Bisceglia M, Cristofaro C, Russo D, Filetti |
|
Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications.
Journal of medical genetics 2004 Mar 41 (3): 155-60. Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, Hill P, Perry-Keene D, Learoyd D, Robinson B, Birdsey P, Mackenzie E, Teh B T, Prins J B, Cardinal |
|
Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Endocrine 2004 Feb 23 (1): 45-9. Sakurai Akihiro, Katai Miyuki, Yumita Wataru, Minemura Kesami, Hashizume Kiyos |
|
Multiple endocrine neoplasia type 1 polymorphism D418D is associated with sporadic primary hyperparathyroidism.
Surgery 2002 Sep 132 (3): 450-5. Correa Pamela, Lundgren Ewa, Rastad Jonas, åkerström Göran, Westin Gunnar, Carling Tobi |
|
Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
The Journal of clinical endocrinology and metabolism 2002 Feb 87 (2): 457-65. Vergès Bruno, Boureille Françoise, Goudet Pierre, Murat Arnaud, Beckers Albert, Sassolas Geneviève, Cougard Patrick, Chambe Béatrice, Montvernay Corinne, Calender Ala |
|
Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families.
World journal of surgery 2001 May 25 (5): 610-6. Kopp I, Bartsch D, Wild A, Schilling T, Nies C, Bergenfelz A, Rieder H, Simon B, Rothmund |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 10, 2019
- Content source: